Aker BioMarine ASA – Invitation to presentation of the first quarter 2026 results

27 Apr 2026 11:57 CEST

Aker BioMarine will release the first quarter 2026 results on Thursday 30 April
2026 at 07:00 CET.

At 08:30 CET on the same day, the management will host a webcast to present the
results. The webcasted presentation will be in English. To join, please use the
link that will be available at www.akerbiomarine.com/investor.

A replay of the presentation will be made available soon after the presentation
at the same web page.

For further information, please contact
Christopher Robin Vinter, SVP Finance
Mobile: +47 911 60 820
Email: christopher.vinter@akerbiomarine.com


About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+,
as well as the consumer brand, Kori Krill. The innovative approach also extends
into the spin-offs AION (reduce and recycle plastic waste across industries) and
Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock
Exchange (AKBM). More information is available at www.akerbiomarine.com.

More information:
Access the news on Oslo Bors NewsWeb site